Lavipharm's granted patent portfolio consists
of a large number of patents covering the whole
spectrum of its technologies and products,
while many new patent applications
are still under examination.


Examples of patents already approved are:

• Transdermal therapeutic system containing oestradiol (for hormone replacement), in USA, Europe and elsewhere.
• Use of a pharmaceutical substance for the treatment of erectile dysfunction in men, in USA and Europe.
• Use of a pharmaceutical substance for the treatment of sexual dysfunction in women, in USA and Europe.
• Drug Delivery Systems based on Slow-Dis^TM technology, in USA.
• Epidermal system against acne prone skin.
• Systems based on the use of natural polymers.
• Methods of processing substances, based on Supercritical Fluids.
• Antioxidant and cyto-protective properties of olives, olive special extracts, olive components and olive oil production wastewater, in Greece and USA.

• Transdermal therapeutic system for pain management.
• Transdermal therapeutic system against hypertension.
• Topically applied systems for the treatment of erectile dysfunction in men and sexual dysfunction in women.
• Self-adhesive systems releasing volatile components.
• Drug delivery systems based on Quick-Dis^TM technology, internationally.
• Drug delivery systems based on Slow-Dis^TM technology, beyond USA.
• Drug delivery systems based on Solid Gel^TM, internationally.
• Drug delivery systems based on Liquid patch^TM technology, internationally
• Technologies that improve the drug taste, for oral delivery systems based on Quick-Dis^TM and Slow-Dis^TM
• Specific forms of manufacturing and packaging of many of the systems mentioned above, internationally.
• Controlled release product containing organic nitrate compounds for the prevention of angina, based on osmotic technology, in Greece.
• Chios mastic properties, internationally.